QQQ   292.37 (+0.72%)
AAPL   143.12 (+0.08%)
MSFT   245.56 (+1.17%)
META   147.99 (+0.63%)
GOOGL   97.68 (+0.76%)
AMZN   102.41 (+1.85%)
TSLA   170.63 (+2.38%)
NVDA   194.21 (+1.35%)
NIO   12.16 (+1.16%)
BABA   110.50 (-0.63%)
AMD   73.80 (+1.86%)
T   20.25 (+0.45%)
MU   60.12 (-2.58%)
F   13.32 (+3.34%)
CGC   2.91 (+2.46%)
GE   80.69 (-0.17%)
DIS   108.29 (+0.65%)
AMC   5.16 (+2.99%)
PFE   43.64 (+0.21%)
PYPL   80.56 (+1.16%)
NFLX   353.33 (+0.06%)
QQQ   292.37 (+0.72%)
AAPL   143.12 (+0.08%)
MSFT   245.56 (+1.17%)
META   147.99 (+0.63%)
GOOGL   97.68 (+0.76%)
AMZN   102.41 (+1.85%)
TSLA   170.63 (+2.38%)
NVDA   194.21 (+1.35%)
NIO   12.16 (+1.16%)
BABA   110.50 (-0.63%)
AMD   73.80 (+1.86%)
T   20.25 (+0.45%)
MU   60.12 (-2.58%)
F   13.32 (+3.34%)
CGC   2.91 (+2.46%)
GE   80.69 (-0.17%)
DIS   108.29 (+0.65%)
AMC   5.16 (+2.99%)
PFE   43.64 (+0.21%)
PYPL   80.56 (+1.16%)
NFLX   353.33 (+0.06%)
QQQ   292.37 (+0.72%)
AAPL   143.12 (+0.08%)
MSFT   245.56 (+1.17%)
META   147.99 (+0.63%)
GOOGL   97.68 (+0.76%)
AMZN   102.41 (+1.85%)
TSLA   170.63 (+2.38%)
NVDA   194.21 (+1.35%)
NIO   12.16 (+1.16%)
BABA   110.50 (-0.63%)
AMD   73.80 (+1.86%)
T   20.25 (+0.45%)
MU   60.12 (-2.58%)
F   13.32 (+3.34%)
CGC   2.91 (+2.46%)
GE   80.69 (-0.17%)
DIS   108.29 (+0.65%)
AMC   5.16 (+2.99%)
PFE   43.64 (+0.21%)
PYPL   80.56 (+1.16%)
NFLX   353.33 (+0.06%)
QQQ   292.37 (+0.72%)
AAPL   143.12 (+0.08%)
MSFT   245.56 (+1.17%)
META   147.99 (+0.63%)
GOOGL   97.68 (+0.76%)
AMZN   102.41 (+1.85%)
TSLA   170.63 (+2.38%)
NVDA   194.21 (+1.35%)
NIO   12.16 (+1.16%)
BABA   110.50 (-0.63%)
AMD   73.80 (+1.86%)
T   20.25 (+0.45%)
MU   60.12 (-2.58%)
F   13.32 (+3.34%)
CGC   2.91 (+2.46%)
GE   80.69 (-0.17%)
DIS   108.29 (+0.65%)
AMC   5.16 (+2.99%)
PFE   43.64 (+0.21%)
PYPL   80.56 (+1.16%)
NFLX   353.33 (+0.06%)
NYSE:PBH

Prestige Consumer Healthcare - PBH Stock Forecast, Price & News

$65.93
+0.44 (+0.67%)
(As of 01/31/2023 12:13 PM ET)
Add
Compare
Today's Range
$65.18
$66.20
50-Day Range
$59.80
$67.05
52-Week Range
$48.51
$67.45
Volume
68,139 shs
Average Volume
242,457 shs
Market Capitalization
$3.27 billion
P/E Ratio
16.00
Dividend Yield
N/A
Price Target
$71.00

Prestige Consumer Healthcare MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
8.4% Upside
$71.00 Price Target
Short Interest
Bearish
2.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
0.86mentions of Prestige Consumer Healthcare in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
5.24%
From $4.20 to $4.42 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.71 out of 5 stars

Consumer Discretionary Sector

209th out of 279 stocks

Pharmaceutical Preparations Industry

393rd out of 518 stocks


PBH stock logo

About Prestige Consumer Healthcare (NYSE:PBH) Stock

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.

Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Stock News Headlines

Apple, Amazon, and Walmart are Investing in Solar Energy
The global market for solar energy is expected to be worth an astronomical $1 trillion by the end of 2028, with increasing adoption of solar by commercial, non-profit, and public entities. Even Fortune 500 companies such as Apple, Amazon, and Walmart are investing in solar to help save money over the long term. So it's little wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.
Apple, Amazon, and Walmart are Investing in Solar Energy
The global market for solar energy is expected to be worth an astronomical $1 trillion by the end of 2028, with increasing adoption of solar by commercial, non-profit, and public entities. Even Fortune 500 companies such as Apple, Amazon, and Walmart are investing in solar to help save money over the long term. So it's little wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.
Factors Working Well for Prestige Consumer
Holding Prestige Consumer Healthcare
See More Headlines
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Company Calendar

Last Earnings
11/03/2022
Today
1/31/2023
Next Earnings (Confirmed)
2/02/2023
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
CUSIP
74112D10
Employees
505
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$71.00
High Stock Price Forecast
$72.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+7.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$205.38 million
Pretax Margin
23.83%

Debt

Sales & Book Value

Annual Sales
$1.09 billion
Cash Flow
$4.85 per share
Book Value
$31.43 per share

Miscellaneous

Free Float
48,734,000
Market Cap
$3.27 billion
Optionable
Optionable
Beta
0.57

Key Executives

  • Ronald M. LombardiRonald M. Lombardi
    Chairman, President & Chief Executive Officer
  • Jeff Zerillo
    Senior Vice President-Operations
  • Christine Sacco
    Chief Financial Officer
  • William C. P'Pool
    Secretary, Senior Vice President & General Counsel
  • Adel Mekhail
    Executive Vice President-Marketing & Sales













PBH Stock - Frequently Asked Questions

Should I buy or sell Prestige Consumer Healthcare stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PBH shares.
View PBH analyst ratings
or view top-rated stocks.

What is Prestige Consumer Healthcare's stock price forecast for 2023?

5 brokerages have issued 1-year target prices for Prestige Consumer Healthcare's stock. Their PBH share price forecasts range from $70.00 to $72.00. On average, they expect the company's stock price to reach $71.00 in the next twelve months. This suggests a possible upside of 8.4% from the stock's current price.
View analysts price targets for PBH
or view top-rated stocks among Wall Street analysts.

How have PBH shares performed in 2023?

Prestige Consumer Healthcare's stock was trading at $62.60 at the start of the year. Since then, PBH stock has increased by 4.6% and is now trading at $65.49.
View the best growth stocks for 2023 here
.

When is Prestige Consumer Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our PBH earnings forecast
.

How can I listen to Prestige Consumer Healthcare's earnings call?

Prestige Consumer Healthcare will be holding an earnings conference call on Thursday, February 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc. (NYSE:PBH) announced its quarterly earnings results on Thursday, November, 3rd. The company reported $1.02 EPS for the quarter, topping analysts' consensus estimates of $1.00 by $0.02. The company had revenue of $289.27 million for the quarter, compared to the consensus estimate of $282.93 million. Prestige Consumer Healthcare had a trailing twelve-month return on equity of 12.88% and a net margin of 18.83%.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare issued an update on its FY 2023 earnings guidance on Thursday, November, 10th. The company provided earnings per share (EPS) guidance of $4.18-$4.23 for the period, compared to the consensus EPS estimate of $4.20. The company issued revenue guidance of $1.12 billion-$1.13 billion, compared to the consensus revenue estimate of $1.12 billion.

What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO?

8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA).

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by many different retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (2.14%), Rice Hall James & Associates LLC (1.26%), Ziegler Capital Management LLC (0.44%), Wedge Capital Management L L P NC (0.32%), Comerica Bank (0.16%) and Congress Asset Management Co. MA (0.15%). Insiders that own company stock include Mary Beth Fritz and Ronald M Lombardi.
View institutional ownership trends
.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $65.49.

How much money does Prestige Consumer Healthcare make?

Prestige Consumer Healthcare (NYSE:PBH) has a market capitalization of $3.24 billion and generates $1.09 billion in revenue each year. The company earns $205.38 million in net income (profit) each year or $4.12 on an earnings per share basis.

How many employees does Prestige Consumer Healthcare have?

The company employs 505 workers across the globe.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The official website for the company is www.prestigebrands.com. The company can be reached via phone at (914) 524-6800, via email at irinquiries@prestigebrands.com, or via fax at 302-674-5266.

This page (NYSE:PBH) was last updated on 1/31/2023 by MarketBeat.com Staff